Peptide Therapeutics Industry News In October 2025, Kazia Therapeutics partnered with QIMR Berghofer to develop NDL2, a first-in-class bicyclic peptide degrader targeting resistant PD-L1 forms
Inquire about frequency and dosage : If your doctor suggests using laxatives, ask how often you should take them and what dose is best
The symptoms of hypoglycemia may be masked by alcohol intoxication, making detection and treatment more challenging
Retrieved from Wharton, S., Lingvay, I., Bogdanski, P., et al
Simple linear peptides (5-20 amino acids) require fewer analytical techniques compared to cyclic peptides, peptides with disulfide bonds, or those containing non-standard amino acids
the lipidated peptide has limited solubility at pH 2 to 6